Welcome to LookChem.com Sign In|Join Free
  • or
1-[4-(4-Aminophenyl)-1-piperazinyl]-2,2,2-trifluoro-ethanone is a trifluoro-ethanone derivative with a molecular formula C13H15F3N2O. It features a piperazine ring and an aminophenyl group, which may contribute to its potential biological activity. The trifluoro-ethanone moiety could provide lipophilic properties, while the piperazine ring and aminophenyl group may allow for interactions with biological targets such as receptors or enzymes.

193903-35-4

Post Buying Request

193903-35-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

193903-35-4 Usage

Uses

Used in Pharmaceutical Applications:
1-[4-(4-Aminophenyl)-1-piperazinyl]-2,2,2-trifluoro-ethanone is used as a pharmaceutical candidate for potential applications due to its structural features that may impart biological activity. Its lipophilic properties and the ability to interact with biological targets make it a compound of interest for further research and characterization in the development of new drugs.
Used in Biomedical Applications:
In the Biomedical Industry, 1-[4-(4-Aminophenyl)-1-piperazinyl]-2,2,2-trifluoro-ethanone is used as a compound with potential for biomedical research and development. Its unique structural features may allow for targeted interactions with biological systems, offering opportunities for the creation of novel therapies and diagnostic tools.

Check Digit Verification of cas no

The CAS Registry Mumber 193903-35-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,9,0 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 193903-35:
(8*1)+(7*9)+(6*3)+(5*9)+(4*0)+(3*3)+(2*3)+(1*5)=154
154 % 10 = 4
So 193903-35-4 is a valid CAS Registry Number.

193903-35-4Upstream product

193903-35-4Downstream Products

193903-35-4Relevant academic research and scientific papers

VEGFR TYROSINE KINASE INHIBITORS

-

Page/Page column 32; 33, (2014/12/12)

Novel compounds, their prodrugs, and the pharmaceutically acceptable salts as pharmaceutical compositions containing such compounds useful in treating certain diseases modulated by the inhibition of vascular endothelial growth factors (VEGFs) receptor tyrosine kinases are provided. In particular, compounds and compositions and the methods for the prophylaxis, management and treatment of cancers through the inhibition of VEGF receptor tyrosine kinases are provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 193903-35-4